Seeing Is Believing

Currently out of the existing stock ratings of Chris Schott, 9 are a SELL (4.29%), 54 are a HOLD (25.71%), 147 are a BUY (70%).
Analyst Chris Schott, currently employed at JPMORGAN, carries an average stock price target met ratio of 43.11% that have a potential upside of 21.33% achieved within 262 days.
Chris Schott’s has documented 418 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 06-Oct-2025.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) at 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%) receiving and performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$242
$14.01 (6.15%)
$216
7 days ago
(19-Oct-2025)
27/28 (96.43%)
$9.94 (4.28%)
437
Buy
$250
$22.01 (9.65%)
$220
10 days ago
(16-Oct-2025)
13/14 (92.86%)
$20.43 (8.90%)
399
Buy
$284
$56.01 (24.57%)
$220
17 days ago
(09-Oct-2025)
43/44 (97.73%)
$53.5 (23.21%)
593
Hold
$251
$23.01 (10.09%)
$205
24 days ago
(02-Oct-2025)
15/16 (93.75%)
$17.09 (7.31%)
300
Buy
$270
$42.01 (18.43%)
$195
1 months 10 days ago
(16-Sep-2025)
2/3 (66.67%)
$49.19 (22.28%)
121
Which stock is Chris Schott is most bullish on?
Which stock is Chris Schott is most reserved on?
What Year was the first public recommendation made by Chris Schott?